1. Home
  2. LWAY vs XOMA Comparison

LWAY vs XOMA Comparison

Compare LWAY & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LWAY

Lifeway Foods Inc.

HOLD

Current Price

$22.11

Market Cap

347.2M

ML Signal

HOLD

Logo XOMA Corporation

XOMA

XOMA Corporation

HOLD

Current Price

$24.00

Market Cap

308.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LWAY
XOMA
Founded
1986
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
347.2M
308.6M
IPO Year
1987
N/A

Fundamental Metrics

Financial Performance
Metric
LWAY
XOMA
Price
$22.11
$24.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$35.00
$63.25
AVG Volume (30 Days)
49.7K
563.3K
Earning Date
03-13-2026
03-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.74
0.82
Revenue
$204,069,000.00
$47,106,000.00
Revenue This Year
$15.23
$77.29
Revenue Next Year
$13.72
$29.30
P/E Ratio
$29.61
$28.69
Revenue Growth
12.14
118.02
52 Week Low
$19.50
$18.35
52 Week High
$34.20
$39.92

Technical Indicators

Market Signals
Indicator
LWAY
XOMA
Relative Strength Index (RSI) 46.87 39.03
Support Level $21.25 $22.29
Resistance Level $22.50 $27.87
Average True Range (ATR) 0.64 1.48
MACD 0.06 -0.20
Stochastic Oscillator 40.61 23.57

Price Performance

Historical Comparison
LWAY
XOMA

About LWAY Lifeway Foods Inc.

Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir which is a cultured dairy product. Its product categories are Drinkable Kefir which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir and Other dairy. The company manufacture and market products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products through direct sales force, brokers, and distributors.

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

Share on Social Networks: